GlassScriptPhysician profile
Dickran Vahe Altounian
NPI 1063862290
$2,890.72
in general payments reported to CMS, 2019-2025
14 companies · $401 in 2025
The $401 reported for 2025 was less than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
See the full distribution for Pain Medicine (Physical Medicine & Rehabilitation)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $38.27 · 2021: $2,022 · 2022: $175 · 2023: $168 · 2024: $87.22 · 2025: $401.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $656.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $655.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $1,642.19 | 2021-2023 | Intellis Adaptivestim |
| Boston Scientific Corporation | $399.37 | 2021-2025 | Accolade Sr |
| Nalu Medical, INC. | $233.65 | 2021-2024 | Nalu Neurostimulation System |
| Miach Orthopaedics, INC. | $175.56 | 2025 | |
| Abbott Laboratories | $89.76 | 2021 | |
| Saluda Medical Americas, INC. | $65.84 | 2024 | Evoke |
| Amgen INC. | $56.83 | 2021 | |
| Merz Pharmaceuticals, LLC | $39.19 | 2025 | Xeomin |
| Stryker Corporation | $38.24 | 2025 | Mild Device Kit |
| Vertex Pharmaceuticals Incorporated | $34.16 | 2025 | |
| Ossur Americas, INC. | $27.63 | 2025 | Unloader One X |
| Stimwave Technologies Incorporated | $19.32 | 2021 | |
| Djo, LLC | $16.83 | 2025 | Aircast |
| Piramal Critical Care | $13.88 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dickran Altounian listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.